| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/13/2004 | CN1170574C Areca for giving up smoking and its preparing process |
| 10/13/2004 | CN1170570C Detoxicating ointment for treating burn and scald and its preparing process |
| 10/13/2004 | CN1170565C Cancer treating astringent medicine decoction |
| 10/13/2004 | CN1170562C Medicine for treating tinea |
| 10/13/2004 | CN1170548C Pain relieving ointment and its preparation |
| 10/13/2004 | CN1170547C No-stinking fish-oil composite micro-capsule and preparation process |
| 10/13/2004 | CN1170546C Compound alum powder and its prepn |
| 10/13/2004 | CN1170545C Medical composition for treating tragomaschalia, beriberi and stomatosis |
| 10/13/2004 | CN1170543C Use of PEG-IFN-alpha and triazloe nucleoside for treatment of chronic hepatitis C |
| 10/13/2004 | CN1170542C Oxacarbazepine filme-coated tablets |
| 10/13/2004 | CN1170541C Oral liquid formulations of benzoxazinones HIV reverse transcriptase inhibitors |
| 10/13/2004 | CN1170540C Sustained-release theophylline tablet |
| 10/13/2004 | CN1170539C Antifungal oral composition containing itraconazole and process for preparing same |
| 10/13/2004 | CN1170538C Farnesyl protein transferase inhibitors for treating arthropathies |
| 10/13/2004 | CN1170537C Substituted 1-(piperidin-4-yl)3-(aryl)-isothioureas, ther prepn. and therapeutic use |
| 10/13/2004 | CN1170536C Use of preparing medicine for preventing vomit using tetrahydrobenzo [cd] indole-6-formylamine compound |
| 10/13/2004 | CN1170535C Use of medicine for treatment of migraikne by the administration of alpha-lipoic acid |
| 10/13/2004 | CN1170534C Pharmaceutical compositions containing lipase inhibitors |
| 10/13/2004 | CN1170533C Pharmaceutically stable oxaliplatinum preparation for parenteral administration |
| 10/13/2004 | CN1170532C 2-aminotetralin derivatives for therapy of glaucoma |
| 10/13/2004 | CN1170531C Preparation and application of seleno-methinoine chrome yellow urea as hypoglycemic |
| 10/13/2004 | CN1170530C Patch containing 4-biphenylacetic acid |
| 10/13/2004 | CN1170529C Application of 15-deoxidat6ion IgA |
| 10/13/2004 | CN1170528C Utilization of inhibitors of KQT1 channel in order to produce medicament for treating diseases which are caused by parasitic helminths and actoparasites |
| 10/13/2004 | CN1170524C Fentanyl composition for treatment of acute pain |
| 10/12/2004 | USRE38624 Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and process for their preparation |
| 10/12/2004 | US6803484 Sulfonamide derivatives |
| 10/12/2004 | US6803481 Treating different types and symptoms of acute and chronic pain, especially non neuropathic inflammatory pain in mammals. the pain to be treated may be e.g. chronic inflammatory pain, rheumatoid arthritis pain and/or secondary |
| 10/12/2004 | US6803480 Therapeutic treatment and/or prophylaxis of arteriosclerosis and hypercholesterolaemia |
| 10/12/2004 | US6803479 Reagents and method for spatio-temporal control of gene expression by illumination |
| 10/12/2004 | US6803460 Acidification; carbonation |
| 10/12/2004 | US6803455 Inhibitors of nucleoside metabolism |
| 10/12/2004 | US6803453 Using antibodies directed to a novel class or family of transforming growth factor (tgf)-beta binding proteins; for diagnosis, prevention, treatment of osteoporosis |
| 10/12/2004 | US6803387 Treatment of neuropathic pain or fibromyalgia |
| 10/12/2004 | US6803386 Prostacyclin derivative containing compositions and methods of using the same for the treatment of cancer |
| 10/12/2004 | US6803384 Diaminopropionic acid derivatives |
| 10/12/2004 | US6803380 5-aryl-1h-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them |
| 10/12/2004 | US6803379 Pharmacological agents and methods of treatment that inactivate pathogenic prokaryotic and eukaryotic cells and viruses by attacking highly conserved domains in structural metalloprotein and metalloenzyme targets |
| 10/12/2004 | US6803378 For therapy and prophylaxis of acquired immune deficiency syndrome (aids), or arc |
| 10/12/2004 | US6803376 Method of use of quinolone compounds against pneumococcal and haemophilus bacteria |
| 10/12/2004 | US6803375 Immunomodulation in a mammalian patient without causing substantial inhibition of cytochrome p-450 |
| 10/12/2004 | US6803373 Synergistic mixtures; enhanced absorption |
| 10/12/2004 | US6803372 Such as cis-n-(4-benzoylphenyl)-4-hydroxy-3'-oxospiro (cyclohexane-1,1' (3'h)-isobenzofuran)-4-carboxamide for use as neuropeptide y receptor antagonist for treatment bulimia, obesity or diabetes |
| 10/12/2004 | US6803371 For treating cellular proliferative and neurodegenerative diseases |
| 10/12/2004 | US6803369 Compounds and methods for the treatment of neoplastic disease |
| 10/12/2004 | US6803366 Agent for improving learning or memory |
| 10/12/2004 | US6803365 Imidazo[1,3,5]triazinones and the use thereof |
| 10/12/2004 | US6803364 Il-5 inhibiting 6-azauracil derivatives |
| 10/12/2004 | US6803363 Peritoneal dialysis solution with taurolidine |
| 10/12/2004 | US6803362 Heterocyclic compounds |
| 10/12/2004 | US6803361 Administering nucleotide sequence |
| 10/12/2004 | US6803357 Inhibitors of dipeptidylpeptidase iv (dpiv) sufficient to treat type ii diabetes but not sufficient to suppress the immune system |
| 10/12/2004 | US6803211 Cancer therapy |
| 10/12/2004 | US6803198 Carbamate-derivatized nucleosides and oligonucleosides |
| 10/12/2004 | US6803189 Methods for the detection of cervical cancer |
| 10/12/2004 | US6803060 Composition to boost libido |
| 10/12/2004 | US6803055 Sustained release; benzazole ring structure; psychological disorders |
| 10/12/2004 | US6803053 Condensed nucleic acid/lipid complex for increasing shelf life and high transfection activity in vivo following intravenous injection |
| 10/12/2004 | US6803052 Use of biodegradable microspheres that release an anticancer agent for treating gliobastoma |
| 10/12/2004 | US6803039 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM |
| 10/12/2004 | US6803031 Aerosol comprises particles comprising at least 10 percent by weight of an erectile dysfunction drug, such as sildenafil, tadalafil or vardenafil. |
| 10/12/2004 | CA2387401C Compositions, methods and systems for the production of enediynes |
| 10/12/2004 | CA2306772C Use of c18 to c26 aliphatic alcohols for the manufacture of a medicament in the treatment of hyperproliferative skin disorders |
| 10/12/2004 | CA2170394C Process for conditioning substances |
| 10/12/2004 | CA2146006C Use of ergoline derivatives for the treatment of glaucoma |
| 10/12/2004 | CA2100817C Heteroacetic acid derivatives |
| 10/07/2004 | WO2004086412A2 Radiation protection by gamma-tocotrienol |
| 10/07/2004 | WO2004085712A2 Multi-functional polymeric materials and their uses |
| 10/07/2004 | WO2004085666A2 Secreted proteins |
| 10/07/2004 | WO2004085642A1 Arthritis-associated gene and use thereof in examining arthritis |
| 10/07/2004 | WO2004085582A2 Lipid-improving agent and composition containing lipid-improving agent |
| 10/07/2004 | WO2004085508A1 Methods of performing medical procedures which promote bone growth, compositions which promote bone growth, and methods of making such compositions |
| 10/07/2004 | WO2004085486A1 Composition for external use on skin |
| 10/07/2004 | WO2004085470A1 Interferon-alpha induced gene |
| 10/07/2004 | WO2004085462A2 Method and composition for decreasing ghrelin levels |
| 10/07/2004 | WO2004085459A1 Oestrogen derivatives as inhibitors of steroid sulphatase |
| 10/07/2004 | WO2004085457A2 17beta-hydroxysteroid dehydrogenase inhibitors |
| 10/07/2004 | WO2004085451A2 Office products containing antimicrobial agent |
| 10/07/2004 | WO2004085448A2 Unsaturated phosphinyl-phosphonate phosphate transport inhibitors |
| 10/07/2004 | WO2004085444A1 Cephalosporin in crystalline form |
| 10/07/2004 | WO2004085434A1 Novel oxazole derivatives, their manufacture and use as pharmaceutical agents |
| 10/07/2004 | WO2004085431A1 Prostaglandin analogs as ep4 receptor antagonists |
| 10/07/2004 | WO2004085430A1 Prostaglandin analogs as ep4 receptor agonists |
| 10/07/2004 | WO2004085429A1 Composition for promoting production of type i collagen and/or elastin |
| 10/07/2004 | WO2004085422A1 Water-soluble thalidomine derivatives |
| 10/07/2004 | WO2004085421A2 Bioreductively-activated prodrugs |
| 10/07/2004 | WO2004085416A1 Novel crystalline forms of (s)-citalopram oxalate |
| 10/07/2004 | WO2004085399A1 Oxamide derivatives useful as raf-kinase inhibitors |
| 10/07/2004 | WO2004085396A1 Preventive or therapeutic agent for ischemia/reperfusion injury, organ preservative, and screening method |
| 10/07/2004 | WO2004085389A1 Lipid metabolism improving agent |
| 10/07/2004 | WO2004085388A2 Cyclic protein tyrosine kinase inhibitors |
| 10/07/2004 | WO2004085345A2 15α-SUBSTITUTED ESTRADIOL CARBOXYLIC ACID ESTERS AS LOCALLY ACTIVE ESTROGENS |
| 10/07/2004 | WO2004084952A1 In vivo method for detecting dopamine d3 receptors ligands. |
| 10/07/2004 | WO2004084945A1 Eating controllers |
| 10/07/2004 | WO2004084944A1 Novel blood sugar regulating agent and method of screening the same |
| 10/07/2004 | WO2004084942A2 Methods and means to suppress symptoms of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (gitr or tnfrsf18) |
| 10/07/2004 | WO2004084934A1 Asthma preparation |
| 10/07/2004 | WO2004084933A1 Elevation of adenosine level by cytokine-induced expression of cd73 |
| 10/07/2004 | WO2004084932A2 Use of clusterin for the treatment and/or prevention of peripheral neurological diseases |
| 10/07/2004 | WO2004084931A1 Use of chemokine receptor agonists for stem cell transplantation |